tbuckley/cabot-search huggingface dataset:
Clonal Hematopoiesis Is Common in Long-Term Survivors of Pediatric Hematopoietic Cell Transplantation, Including Umbilical Cord Blood Transplantation
Authors: Konradin F. Müskens, Maaike G.J.M. van Bergen, Aniek O. de Graaf, Nienke Wieringa, Brigit M. te Pas, Anne P.J. de Pagter, Joëll E. Bense, Arjan C. Lankester, Leontien C.M. Kremer, Joop H. Jansen, Geert A. Huls, Stefan Nierkens, Caroline A. Lindemans, Mirjam E. Belderbos
Journal: Blood (2023)
Metabolic Reprogramming By PRDM16 Drives Cytarabine Resistance in Acute Myeloid Leukemia
Authors: Junji Ikeda, Hiroyoshi Kunimoto, Yusuke Saito, Shin-Ichi Tsujimoto, Takayuki Kurosawa, Masanobu Takeuchi, Ayaka Miura, Koichi Murakami, Ikuma Kato, Takako Hishiki, Noriyo Hayakawa, Tomomi Matsuura, Megumi Funakoshi-Tago, Akihiko Yokoyama, Kenichi Yoshida, Daisuke Tomizawa, Satoru Miyano, Akio Tawa, Souichi Adachi, Seishi Ogawa, Yasuhide Hayashi, Norio Shiba, Tomohiko Tamura, Shuichi Ito, Hideaki Nakajima
Journal: Blood (2023)
Influence of Pre-Treatment Features and Therapy Choice By Physicians on Overall Survival in Older Adults with Acute Myeloid Leukemia: A Report from the Beat AML Master Trial
Authors: Uma M. Borate, Ying Huang, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L Lin, Yazan F. Madanat, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, William Blum, Martha Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor J. Kovacsovics, Michael W. Deininger, Joshua F. Zeidner, Rebecca Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily K Curran, Kristin L Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Gullen Marcus, Leonard Rosenberg, Brian J. Druker, Ross L Levine, Amy Burd, Ashley Owen Yocum, Alice Mims, John C. Byrd
Journal: Blood (2023)
Intensive Induction Chemotherapy Vs Hypomethylating Agents + Venetoclax (HMA/VEN) in <i>NPM1</i>-Mutant Newly Diagnosed Acute Myeloid Leukemia (AML) - a Multicenter Cohort Study
Authors: Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, Yiwen Liu, Eva Johanna Schaefer, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Guido Marcucci, R. Coleman Lindsley, Evan C. Chen, Jorge Ramos, Anthony Selwyn Stein, Daniel J. DeAngelo, Donna S. Neuberg, Richard M Stone, Brian J. Ball, Maximilian Stahl
Journal: Blood (2023)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN):Multi-Center Collaboration and Global Registry Program
Authors: Astghik Voskanyan, Maria Badikyan, Marina Y. Konopleva, Alvaro J. Alencar, Arusyak Ivanyan, Carolyn Owen, Consolato Sergi, Ching-Tien Peng, Dickran Kazandjian, Funda Tekkesin, Hasanein Ghali, Karen Bedirian, Maria Paola Martelli, Enrico Attardi, Maria Teresa Voso, Mariam Abramashvili, Mazin Faisal Al-Jadiry, Michalis Michael, Min-Yu Su, Nare Martirosyan, Nino Totogashvili, Pavel P Kotoucek, Rejin Kebudi, Robin Ohannessian, Ruzanna Papyan, Salma Elashwah, Sameer Bakhshi, Samvel Bardakhchyan, Samvel Danelyan, Shaimaa El-Ashwah, Tezer Kutluk, Gevorg Tamamyan, Naveen Pemmaraju
Journal: Blood (2023)
Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with <i>MYC/BCL2</i> and/or <i>BCL6</i> Rearrangements: A Single Center Experience
Authors: Jennifer Kimberly Lue, Efrat Luttwak, Philip Caron, Alexander P. Boardman, Kevin A. David, Alfredo Rivas-Delgado, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Yanming Zhang, Pallavi Galera, Ahmet Dogan, Umut Aypar, Gilles Salles
Journal: Blood (2023)
Pregnancy and Immune Mediated Thrombotic Thrombocytopenic Purpura (iTTP); A Descriptive Analysis from the U.S. Thrombotic Microangiopathy (USTMA) Registry
Authors: Camila Masias, Meera Sridharan, Richard Burwick, Frank Akwaa, Radhika Gangaraju, Anuja Java, Marshall Mazepa, Senthil Sukumar, Ana G. Antun
Journal: Blood (2023)
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Authors: Haydar Frangoul, Franco Locatelli, Akshay Sharma, Monica Bhatia, Markus Mapara, Lyndsay Molinari, Donna Wall, Robert I. Liem, Paul Telfer, Ami J. Shah, Marina Cavazzana, Selim Corbacioglu, Damiano Rondelli, Roland Meisel, Laurence Dedeken, Stephan Lobitz, Mariane de Montalembert, Martin H. Steinberg, Mark C. Walters, Laura Bower, Suzan Imren, Christopher Simard, Fengjuan Xuan, Weiyu Zhou, Phuong Khanh Morrow, William Hobbs, Stephan Grupp
Journal: Blood (2023)
<i>Whole Genome Classification of Pre-Malignant B-Cells Disorder of the Oxplored Study</i>
Authors: Pauline Robbe, Kate Ridout, Niamh Appleby, Georgeta Ciuban, Gagandeep Batth, Helene Dreau, Thomas Wenban-Smith, Melinda Kormandy, Grigore-Aristide Gafencu, Piero Carninci, Clare Freestone, Daniel McAleese, Dimitrios Vavoulis, Anna Schuh
Journal: Blood (2023)
Optical Genomic Mapping Provides Unique Findings in Various Types of Myeloid Neoplasms
Authors: Andres E Quesada, Gokce A. Toruner, Zhenya Tang, Shimin Hu, Jie Xu, Shaoying Li, Farhad Ravandi, Hagop M. Kantarjian, M. James You, L. Jeffrey Medeiros, Guilin Tang
Journal: Blood (2023)
Gene Correction of DNMT3A:R882H in Primary Human AML Demonstrates That This Mutation Is Not Required for Disease Maintenance, but Is Associated with Increased Leukemia Stem Cell Frequency
Authors: Thomas Koehnke, Daiki Karigane, Eleanor Hilgart, Kensuke Kayamori, Amy C Fan, Cailin T Collins, Fabian P Suchy, Athreya S Rangavajhula, Yang Feng, Yusuke Nakauchi, Eduardo Martinez-Montes, Michael Koldobskiy, Andy Feinberg, Ravindra Majeti
Journal: Blood (2023)
A First-in-Human Phase 1 Study of ABBV-525, a Small-Molecule MALT1 Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Authors: Andrew L. Sochacki, Jan A. Burger, Carrianne Ludwig, Wissam Assaily, Wijith Munasinghe, William Pappano, Edward Greenberg, Christine Will, Meghan C. Thompson
Journal: Blood (2023)
The Methylome Atlas of Acute Leukemia Enables Novel Clinical Diagnostic Tool for AML
Authors: Francisco Marchi, Marieke Landwehr, Fernando Sckaff, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Alan S Gamis, E. Anders Kolb, Richard Aplenc, Stanley Pounds, Todd A. Alonzo, Soheil Meshinchi, Jatinder K. Lamba
Journal: Blood (2023)
SNAP: Supportive Non-Invasive Ventilation for ACS Prevention in Hospitalized Children with Sickle Cell Disease: Perceptions of Patients, Caregivers, and the Health Care Team
Authors: Shana A. Burrowes, Christopher J. Williams, Caitlin M. Neri, Elizabeth S. Klings, Kayla C. Jones, Allan J. Walkey, Mari-Lynn Drainoni, Robyn T. Cohen
Journal: Blood (2023)
Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression
Authors: Benoît Tisserand, Caroline Bret, Yassine Al Tabaa, Sylvain Lamure, Xavier Ayrignac, Laura Platon, Patrice Ceballos, Ludovic Gabellier, Jerome Moreaux, Charles Herbaux, Guillaume Cartron, Jean-Jacques Tudesq
Journal: Blood (2023)
Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
Authors: Fred Saad, Paula del Rosario, Noel W. Clarke
Journal: European Urology (2023)
Efficacy and Tolerance of Isatuximab, Cyclophosphamide, Bortezomib, and Dexamethasone (Isa-CBD) Induction Chemotherapy in Newly Diagnosed, Transplant Eligible Multiple Myeloma: Report of the Phase 2 Multi-Centre, Open Label Canadian Myeloma Research Group (CMRG)-008 Prospective Clinical Trial
Authors: Rami Kotb, Darrell White, Sita Bhella, Arleigh McCurdy, Irwindeep Sandhu, Hira Mian, Julie Stakiw, Ibraheem Othman, Jiandong Su, Aniba Khan, Engin Gul, Donna Reece
Journal: Blood (2023)
Personal and Shared Tumor-Antigen Prioritization in Diffuse Large B Cell Lymphoma Patients Undergoing CD19 CAR T Cell Treatment
Authors: Dimitra Karagkouni, Xanthi Lida Katopodi, Giulia Cheloni, Yuling Ma, Brodie Miles, Gayatri Tiwari, Jenny J. Kim, Mike Mattie, Jacalyn Rosenblatt, David Avigan, Ioannis Vlachos
Journal: Blood (2023)
Mechanisms of Resistance and Relapse with Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 MonumenTAL-1 Study
Authors: Deeksha Vishwamitra, Sheri Skerget, Diana Cortes, Onsay Lau, Cuc Davis, Thomas Renaud, Jaszianne Tolbert, Brandi W Hilder, Tara J Masterson, Michela Campagna, Christoph Heuck, Ajai Chari, Niels WCJ van de Donk, Raluca Verona
Journal: Blood (2023)
Cytoreductive Chemotherapy in Induction Therapy Plays a Key Role in the Prognosis of Patients with Low-Risk Acute Promyelocytic Leukemia
Authors: Xiaolu Zhu, Feifei Tang, Wenjing Yu, Xiaosu Zhao, Yazhen Qin, Qian Jiang, Xiao Jun Huang, Hao Jiang
Journal: Blood (2023)
Association between High Antimetabolite Dose Intensity during Maintenance, Toxicities and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): COG-AALL03N1 Report
Authors: Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anne Angiolillo, David Dickens, Joseph Neglia, Yaddanapudi Ravindranath, Amanda Muench Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia
Journal: Blood (2023)
Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Authors: Austin I Kim, Philippe Armand, Robert A. Redd, Megan Forsyth, Paul Branch, Samantha Pazienza, Lisa Brennan, Victoria Patterson, Susan M Waisgerber, Reid W. Merryman, David C Fisher, Christine E. Ryan, Inhye E Ahn, Jennifer L Crombie, Oreofe O. Odejide, Ann LaCasce, Caron A Jacobson, Eric Jacobsen, Erin M Parry, Matthew S Davids, Jennifer R. Brown, Arnold S. Freedman, Peter A. Riedell, Mark Alan Murakami
Journal: Blood (2023)
Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study
Authors: Makoto Iwasaki, Junya Kanda, Fumihiko Kimura, Sachiko Seo, Yoshiko Atsuta, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Tetsuya Nishida, Yuta Katayama, Masatsugu Tanaka, Tetsuya Eto, Kazuhiro Ikegame, Yoshinobu Kanda, Masashi Sawa, Makoto Onizuka, Moeko Hino, Tatsuo Ichinohe, Ken Tabuchi, Akifumi Takaori-Kondo
Journal: Blood (2023)
Multimodal Mobile Application to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HCT) Survivors
Authors: Areej El-Jawahri, Jennifer Reese, Lara Traeger, Don Dizon, Sharon Bober, Julie Vanderklish, Richard Newcomb, Zachariah Defilipp, Yi-Bin Chen, Jennifer Temel
Journal: Blood (2023)
First-Time Users of Advanced Therapies Among Adult Patients with Persistent or Chronic Primary Immune Thrombocytopenia: Patient Characteristics, Treatment Switching Patterns, and Clinical Outcomes
Authors: David J Kuter, Imene Gouia, Matias Cordoba, Brad Ward, Ines Hemim, Duane Madziva, Natalia Petruski-Ivleva
Journal: Blood (2023)
Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study
Authors: Sylvain Garciaz, Sarah Bertoli, David A Sallman, Justine Decroocq, Pierre-Yves Dumas, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Ludovic Gabellier, Marie Anne Hospital, Ariane Mineur, Arnaud Pigneux, Norbert Vey, Christian Récher
Journal: Blood (2023)
Identification of Optimal Dosing Regimen for Subcutaneous Epcoritamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Authors: Tommy Li, Leonid Gibiansky, Apurvasena Parikh, Christopher W. Chiu, Mariana Sacchi, Huaibao Feng, Tahi Ahmadi, Manish Gupta, Steven Xu
Journal: Blood (2023)
Patient-Reported Outcomes (PROs) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Eculizumab: Results from the Phase III Randomized COMMODORE 2 and COMMODORE 1 Trials
Authors: Jens Panse, Jaroslav Cermak, Olena Kyselova, Akihiko Gotoh, Fahri Sahin, Hubert Schrezenmeier, Alice C. Chang, Brittany Gentile, Marianne Uguen, Bing Han
Journal: Blood (2023)
Dynamic Recruitment of Inhibitory Complexes Controls Oncogenic Signaling in B-Cell Malignancies
Authors: Ruifeng Sun, Jaewoong Lee, Mark E Robinson, Kohei Kume, Ning Ma, Kadriye Nehir Cosgun, Lai N Chan, Irina Antoshkina, Dhruv Khanduja, Etienne Leveille, Samuel G. Katz, Jianjun Chen, Elisabeth Paietta, Nagarajan Vaidehi, Markus Müschen
Journal: Blood (2023)
Clonal Evolution Dissection Reveals High MSI2 Level Promotes Chemo-Resistance in T-Cell Acute Lymphoblastic Leukemia
Authors: Jingliao Zhang, Yongjuan Duan, Peng Wu, Suyu Zong, Wenyu Yang, Li Zhang, Tao Cheng, Xiaofan Zhu, Yingchi Zhang
Journal: Blood (2023)
Routine Whole Genome Sequencing Offers a More Comprehensive Assessment of IG/TCR Gene Rearrangements for MRD Targets in Acute Lymphoblastic Leukemia - Data from the First 62 Cases from the NHS England Genomic Medicine Service
Authors: Stuart Adams, Jeremy Hancock, Joe Kaplinsky, Alona Sosinsky, Gary Wright, Soragia Athina Gkazi, Susanne Kricke, Rebecca Thomas, Natalie Kent, Angus Hodder, Jack Bartram
Journal: Blood (2023)
Identification of Characteristics and Prognostic Impact of <i>FUS-ERG</i> and <i>AML1-MTG16</i> Fusion Genes in Adult AML Patients
Authors: Ziyue Zhou, Yile Zhou, Caihong Sun, Yiyi Yao, Liping Mao, Yi Zhang, Qing Hong, Nanfang Zhuo, Peifeng Pan, Hongyan Tong, Jie Jin, Huafeng Wang
Journal: Blood (2023)
Efficacy of Subcutaneous Epcoritamab Vs Tisa-Cel in R/R LBCL CAR T-Naive and CAR T-Eligible Patients: An Indirect Comparison
Authors: Gilles Salles, Christopher P. Fox, Anthony Wang, Kavita Sail, Abualbishr Alshreef, Michael Moran, Alex Mutebi, Julie Blaedel, Viktor Chirikov, Wei-Jhih Wang, Catherine Thieblemont
Journal: Blood (2023)
“Dose-Dense” Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves High Rates of Rapid MRD-Negativity in Patients with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: A Retrospective Analysis
Authors: Trevor Jamison, Hagop M. Kantarjian, Shilpa Paul, Branko Cuglievan, David McCall, Nitin Jain, Fadi G. Haddad, Kayleigh R. Marx, Caitlin R Rausch, J. Michael Savoy, Lewis Nasr, Cedric Nasnas, Marianne Zoghbi, Rebecca Garris, Farhad Ravandi, Marina Y. Konopleva, Elias Jabbour, Nicholas J. Short
Journal: Blood (2023)
Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Who Received at Least 2 BCMA-Directed Therapies
Authors: Jordan Snyder, Zain Alsaddi, Omar Alkharabsheh, Barry Paul, Forat Lutfi, Nausheen Ahmed, Zahra Mahmoudjafari, Al-Ola Abdallah, Shebli Atrash
Journal: Blood (2023)
A Novel Adenovirus (Adv)-Vaccinated Murine Model Simulates the Prothrombotic Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Clinical Disorder
Authors: Lubica Rauova, Jenna Oberg, Nate Levine, Khalil Bdeir, Douglas B. Cines, Sarah Gilbert, Mortimer Poncz, Gowthami Arepally
Journal: Blood (2023)
DNA Liquid Biopsies for Cancer-Associated Venous Thromboembolism Prediction
Authors: Justin Jee, Angela Rose Brannon, Chris Fong, Adrian Lee, Lauren Gray, Karl Pichotta, Anisha Luthra, Monica Diosdado, Mohammad Haque, Jiannan Guo, Jennifer Hernandez, Kavita Garg, Andriy Derkach, Clare Wilhelm, Rohan Singh, Maria E. Arcila, Nick Pavlakis, Stephen Clarke, Sohrab P Shah, Pedram Razavi, Jorge Reis-Filho, Marc Ladanyi, Nikolaus Schultz, Jeffrey I. Zwicker, Michael F. Berger, Bob T Li, Simon Mantha
Journal: Blood (2023)
Classification of NK-Large Granular Lymphocytic Leukemia By CD56 Expression
Authors: Li Yuxi, Ying Yu, Yanshan Huang, Rui Cui, Jingwen Sun, Rui Lyu, Tingyu Wang, Wenjie Xiong, Yuting Yan, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Lugui Qiu, Shuhua Yi
Journal: Blood (2023)
Longitudinal Characterization of Hemodynamic Changes with Multimodal Optical Techniques in Patients with Sickle Cell Disease Treated with Mitapivat
Authors: Timothy Quang, Ingrid Frey, Julia Xu, Golnar Mostashari, Anna Conrey, Dina S. Parekh, Ruth Pierre Charles, Brian Hill, Swee Lay Thein, Bruce J Tromberg
Journal: Blood (2023)
Efficacy of Maintenance Therapies By Prognostic Subgroups in Post-Transplant Newly Diagnosed Multiple Myeloma Patients: A Systematic Review and Network Meta-Analysis
Authors: Noureen Asghar, Syed Arsalan Naqvi, Kanwal Asghar, Joseph Thirumalareddy, Noureen Asghar, Muhammad Husnain, Rajshekhar Chakraborty, Bradley Devrieze, Abraham Mathews, Irbaz Bin Riaz, Mohammed Aljama
Journal: Blood (2023)
<i>Perioperative Outcomes and Management in Patients with Myeloproliferative Neoplasms: A Multicentric Retrospective Analysis of 354 Surgical Interventions</i>
Authors: Natasha Szuber, Steve Dagenais-Bellefeuille, Mégane Tanguay, Awatef Shehabeldeen, Saima Ahmed, Michaël Harnois, Jaroslav F. Prchal, Harold J. Olney, Lambert Busque, Shireen Sirhan
Journal: Blood (2023)
FLT3-ITD Induces Immune Escape in AML Via up-Regulating CD47 Expression and Decreased Phagocytic Ability of Macrophages
Authors: Yun Wang, Shuzhao Chen, Limei Zhang, Jiangtao Song, Huaze Liao, Mayan Huang, Kunying Xie, Robert Peter Gale, Yang Liang
Journal: Blood (2023)
<i>BTG2</i> Super-Enhancer Mutations Disrupt TFAP4 Binding and Deregulate BTG2 Expression in Diffuse Large B-Cell Lymphoma
Authors: Pantaleo De Simone, Elodie Bal, Antony Holmes, Laura Hilton, Katia Basso, Rajesh K Soni, Ryan Morin, Riccardo Dalla-Favera, Laura Pasqualucci
Journal: Blood (2023)
The Laip-Based-Dfn Approach Is Superior in Terms of Useful MRD Results As Compared to the Laip Approach after Cycle II in Acute Myeloid Leukemia
Authors: Lok Lam Ngai, Diana Hanekamp, Angèle Kelder, Willemijn Scholten, Jannemieke Carbaat-Ham, Mona M.H.E Fayed, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Tim R. Mocking, Vincent H.J. Van Der Velden, Jennichjen Slomp, Willemijn Hobo, Dimitri Breems, Thomas Fischer, Bjorn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Arjan A. van de Loosdrecht, Gert Ossenkoppele, Jacqueline Cloos
Journal: Blood (2023)
Distinct T Cell Receptor Gene Repertoires and T Cell Subset Distribution in Peripheral Blood and Bone Marrow of Patients with Multiple Myeloma
Authors: Glykeria Gkoliou, Nikolaos Pechlivanis, Sofia Chatzileontiadou, Chara Xydopoulou, Christina Frouzaki, Georgios Karakatsoulis, Elisavet Vlachonikola, Marina Gerousi, Fotis Psomopoulos, Maria Papaioannou, Katerina Chlichlia, Kostas Stamatopoulos, Evdoxia Hatjiharissi, Anastasia Chatzidimitriou
Journal: Blood (2023)
TNC/Kg and CD34+/Kg Cell Dose Impact on Patient Engraftment after Allogeneic Transplant with Conventional Bone Marrow; Better Predictability of Graft Content Needed
Authors: Eric Davis, Elise Feuer, Candice Rapoport, Stephanie Lobaugh, Sean M. Devlin, Anne Archer, Stephanie Chinapen, Jacob Federman, Amanda Kelly, Elizabeth Klein, Melissa Nhaissi, Deborah Wells, Juliet N Barker, Esperanza B. Papadopoulos, Andromachi Scaradavou, Jaap Jan Boelens, Miguel-Angel Perales, Elena Maryamchik, Roni Tamari
Journal: Blood (2023)
A Phase 2 Study of Fedratinib in Patients with MDS/MPN and Chronic Neutrophilic Leukemia
Authors: Andrew T. Kuykendall, Kristen Marie Pettit, Abhay Singh, Tania Jain, David A Sallman, Qianxing Mo, Quan Lovette, Ling Zhang, Onyee Chan, Alison R. Walker, Zhuoer Xie, Jeffrey Lancet, Maria Balasis, Seongseok Yun, Eric Padron, Rami S. Komrokji
Journal: Blood (2023)
Age-Based Comparison of Stem Cell Transplantation during the First Line of Therapy for Multiple Myeloma Patients
Authors: Jorge Arturo Arturo Hurtado Martinez, Jay R. Hydren, Patricia Alejandra Flores Pérez, Mason S. Barnes, Felipe Flores Quiroz, Nathan Sweeney, Karla Mariana Castro Bórquez, Andrea Isabel Robles Espinoza, Jennifer M. Ahlstrom
Journal: Blood (2023)
Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry
Authors: Inés Gómez Seguí, Clara Sopeña Pell-Ilderton, Joan Cid, Miquel Lozano, Maria Eva Mingot Castellano, Maria Cristina Pascual Izquierdo, Luz Maria Gonzalez del Castillo, Julia Maria Vidan Estevez, Faustino Garcia-Candel, Moraima Jiménez Balarezo, David Valcarcel, Clara Cuellar Perez-Avila, Maria Aranzazu Aguirre Arrizabalaga, Laura Francisca Avila Idrovo, Maria Gemma Moreno Jimenez, Ana Yurena Oliva Hernandez, Jose Maria Garcia Gala, Jorge Martínez Nieto, Rosa Goterris, Marta Fernández Docampo, Javier De La Rubia
Journal: Blood (2023)
Ibrutinib and Venetoclax in Symptomatic, Treatment-Naive Patients with Waldenström Macroglobulinemia
Authors: Jorge J. Castillo, Shayna R Sarosiek, Andrew R. Branagan, Catherine A. Flynn, Megan Little, Katherine Stockman, Timothy P. White, Alexandra N. Eurell, Maria Luisa Guerrera, Amanda Kofides, Shirong Liu, Xia Liu, Kris Richardson, Nickolas Tsakmaklis, Kirsten Meid, Christopher J Patterson, Zachary R Hunter, Steven P Treon
Journal: Blood (2023)
Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study
Authors: Andrew L. Feldman, Surendra Dasari, Lisa M. Rimsza, David W. Scott, Naoki Oishi, Catalina Amador, Elias Campo, Wing C. Chan, James R. Cook, Jan Delabie, Pedro Farinha, Kai Fu, Timothy C. Greiner, Giorgio Inghirami, Javeed Iqbal, Elaine S. Jaffe, Sarah L. Ondrejka, German Ott, Stefania Pittaluga, Phil Raess, Andreas Rosenwald, Kerry J. Savage, Graham Slack, Susan L. Slager, Joo Y. Song, Louis M. Staudt, George Wright, Hao-Wei Wang, Yu Zeng, Tadashi Yoshino, Xiaojun Wu, Ryan A. Wilcox, Xueju Wang, Akira Satou, Anamarija M. Perry, Roberto Miranda, L. Jeffrey Medeiros, Matthew J. Maurer, Eric Mou, Young Hyeh Ko, Kennosuke Karube, Brad S. Kahl, Liuyan Jiang, David L Jaye, Laurence de Leval, Weina Chen, Jennifer R. Chapman-Fredricks, James R. Cerhan, Carlos Barrionuevo, Stephen M Ansell, Ahmed Aljudi
Journal: Blood (2023)
Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)
Authors: Michael Tomasson, Shinsuke Iida, Ruben Niesvizky, Mohamad Mohty, Nizar J Bahlis, Joaquin Martinez-Lopez, Guenther Koehne, Paula Rodriguez Otero, H. Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T Sullivan, Alexander Lesokhin
Journal: Blood (2023)
With up to 8 Years of Therapy, Asciminib (ASC) Monotherapy Demonstrated Continued Favorable Efficacy, Safety, and Tolerability in Patients (Pts) with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP) without the T315I Mutation: Final Results from the Phase 1 X2101 Study
Authors: Andreas Hochhaus, Dong-Wook Kim, Jorge Cortes, Koji Sasaki, Michael Mauro, Timothy P Hughes, Massimo Breccia, Moshe Talpaz, Hironobu Minami, Yeow Tee Goh, Daniel J. DeAngelo, Fabian Lang, Michael C. Heinrich, Valle Gomez G De Soria, Philipp le Coutre, Gessami Sanchez-Olle, Jomy Jose, Nathalie Pognan, Shruti Kapoor, Delphine Rea
Journal: Blood (2023)
The Effect of Tucaresol on Translational MRI Estimates of Cerebral Physiology in Townes SCD Mice
Authors: James A. Goodman, Yi-Fen Yen, Yinching Iris Chen, Suk-Tak Chan, Jonah P. Weigand Wittier, Jay M. Janz, Steven Arkin, Denis Rybin, Kelly Marie Knee, Debra D Pittman, Joseph B. Mandeville
Journal: Blood (2023)
Impact of Patient Selection and Management over Different Time Periods on the Outcome of Patients with Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
Authors: Anna Torrent, Mireia Morgades, Gloria Iacoboni, Juan Luis Reguera, Mi Kwon, Lucia Lopez Corral, Rafael Hernani, Valentin Ortiz-Maldonado, Jaime Sanz, Ana Carolina Caballero Gonzalez, Luisa Guerra, Jose Maria Sanchez Pina, Alberto Mussetti, Alejandro Martin Garcia-Sancho, Mariana Bastos-Oreiro, Javier Delgado, Cecilia Carpio, Juan-Manuel Sancho, Antonio Perez Martinez, Pere Barba
Journal: Blood (2023)
Pre-Graft Vaccination or Infection Do Not Provide More Protection Against COVID-19 Infections in Post-Graft Vaccinated Recipients of Allogeneic Stem Cell Transplantation
Authors: Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Alice Garnier, Pierre Peterlin, Maxime Jullien, Chloe Antier, Marie-Christine Béné, Patrice Chevallier
Journal: Blood (2023)